Ananth Prasanna, Reed-Weston Anne, Wolfe Joanne
Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Columbia University College of Physicians and Surgeons, New York, New York.
Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26826. Epub 2017 Sep 19.
Medical marijuana (MM) has become increasingly legal at the state level and accessible to children with serious illness. Pediatric patients with cancer may be particularly receptive to MM, given purported benefits in managing cancer-related symptoms. In this review, we examine the evidence for MM as a supportive care agent in pediatric oncology. We describe the current legal status of MM, mechanism of action, common formulations, and potential benefits versus risks for pediatric oncology patients. We offer suggestions for how providers might approach MM requests. Throughout, we comment on avenues for future investigation on this growing trend in supportive care.
医用大麻在州一级越来越合法化,重病儿童也可获取。鉴于其在管理癌症相关症状方面据称的益处,癌症儿科患者可能对医用大麻尤为接受。在本综述中,我们研究了医用大麻作为儿科肿瘤学支持性护理药物的证据。我们描述了医用大麻的当前法律地位、作用机制、常见剂型以及儿科肿瘤学患者的潜在益处与风险。我们就医疗服务提供者应如何处理医用大麻的请求提供建议。在整个过程中,我们对支持性护理这一日益增长趋势的未来研究途径发表评论。